Nerivio device for amplified musculoskeletal pain in kids
Part of Pain clinical trials.
This trial tests a wearable device called Nerivio to treat amplified musculoskeletal pain syndrome (AMPS) in children. The device sends gentle signals to help calm pain pathways, and you can track your pain using a smartphone app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with amplified musculoskeletal pain syndrome by a doctor who specializes in pediatric pain.
- Had bone, muscle, or joint pain for at least 3 months.
- Rate your average pain as 4 or higher on a scale of 0 (no pain) to 10 (worst pain).
- Able to understand and follow simple instructions to use the device.
- Have a compatible smartphone or device to run the Nerivio app.
- Able to commit to a 4-week treatment and data collection period.
- Be between 8 and 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wearable device that uses mild electrical pulses to treat chronic pain in the knee, arm, or shoulder. It is for people whose pain started after surgery or injury and who have not found enough relief with standard treatments.
This trial tests whether a small non-surgical device can help keep children with steroid-sensitive nephrotic syndrome in remission. If it works, it could lower the chance of relapse (kidney flare-ups) and help maintain kidney health.
This study tests a device that uses mild electrical pulses to reduce nerve pain in children with cancer. It may offer a drug-free way to manage pain.
This trial tests a non-invasive device that stimulates the vagus nerve (a key nerve in your body) to help reduce chronic muscle or joint pain. It is for people whose pain may be linked to problems with the body's automatic functions, like heart rate and digestion.
This Phase 2 study looks at how spinal cord (or nerve-root) stimulation affects pain signals in the brain and body. You may qualify if you already have a stimulator set to a comfort mode that avoids “tingling” sensations.
This trial tests whether a nerve-stimulation treatment can reduce chronic neck and upper arm pain when other treatments haven’t worked. It includes adults who can consent and attend follow-up visits, and it checks for safety with pregnancy prevention and a specific early test after implantation.
Hear when a new Amplified Musculoskeletal Pain Syndrome (AMPS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.